These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 403732)

  • 21. The ultrastructural localization of von Willebrand factor in endothelial cells.
    Warhol MJ; Sweet JM
    Am J Pathol; 1984 Nov; 117(2):310-5. PubMed ID: 6093546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Von Willebrand disease--a variation with an aberrant multimeric structure].
    Batlle Fonrodona J; López Fernández MF; Fernández Villamor A; López Berges C; Lasierra Cirujeda J; López Borrasca A
    Sangre (Barc); 1985; 30(2):146-53. PubMed ID: 3925572
    [No Abstract]   [Full Text] [Related]  

  • 23. Enhanced luminescence enzyme immunoassay for factor VIII related antigen.
    Wang HX; George J; Thorpe GH; Stott RA; Kricka LJ; Whitehead TP
    J Clin Pathol; 1985 Mar; 38(3):317-9. PubMed ID: 3919065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Availability of endothelial von Willebrand factor and platelet function in diabetic patients infused with a vasopressin analogue.
    Porta M
    Diabetologia; 1982 Nov; 23(5):452-5. PubMed ID: 6816652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of proteases in AHF concentrates: effect on factor VIII:von Willebrand protein as assessed by high-pressure gel permeation chromatography.
    Orthner CL
    J Lab Clin Med; 1984 Nov; 104(5):816-28. PubMed ID: 6436416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in scleroderma and in Raynaud's phenomenon.
    Kahaleh MB; Osborn I; LeRoy EC
    Ann Intern Med; 1981 Apr; 94(4 pt 1):482-4. PubMed ID: 6782927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bleeding in renal failure: is von Willebrand factor implicated?
    Remuzzi G; Livio M; Roncaglioni MC; Mecca G; Donati MB; de Gaetano G
    Br Med J; 1977 Aug; 2(6083):359-61. PubMed ID: 302134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Studies on the dynamics of plasma factor VIII/von Willebrand factor activity in cerebrovascular diseases].
    Shinmyozu K; Maruyama Y; Ohkatsu Y; Maruyama I; Igata A
    Rinsho Shinkeigaku; 1983 Feb; 23(2):172-9. PubMed ID: 6407797
    [No Abstract]   [Full Text] [Related]  

  • 29. [Reduction of Willebrand activity in patients with chronic kidney failure].
    Kazatchkine M; Sultan Y; Bariety J; Caen J
    C R Acad Hebd Seances Acad Sci D; 1976 Jul; 283(3):287-9. PubMed ID: 825277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Factor VIII/von Willebrand factor complex (FVIII/vWF)].
    Yoshioka A
    Rinsho Byori; 1985 Feb; Spec No 61():73-85. PubMed ID: 3923232
    [No Abstract]   [Full Text] [Related]  

  • 31. Bleeding in cirrhotic patients: a precipitating factor due to intravascular coagulation or to hepatic failure?
    Bertaglia E; Belmonte P; Vertolli U; Azzurro M; Martines D
    Haemostasis; 1983; 13(5):328-34. PubMed ID: 6418623
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stability of von Willebrand factor in blood stored at 4 degrees C.
    Hondow JA; Russell WJ; Tunbridge LJ; Lloyd JV
    Thromb Res; 1982 Jul; 27(2):125-30. PubMed ID: 6814001
    [No Abstract]   [Full Text] [Related]  

  • 33. Factor VIII (procoagulant activity VIII:C, and antigen VIII:CAg, related antigen VIIIR:Ag and ristocetin cofactor VIIIR:Cof) in intensive care patients with clinically suspected disseminated intravascular coagulation (DIC).
    Tran TH; Lämmle B; Duckert F
    Am J Clin Pathol; 1984 Nov; 82(5):565-72. PubMed ID: 6437209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibronectin and factor VIII-related antigen in liver cirrhosis and acute liver failure.
    Höfeler H; Klingemann HG
    J Clin Chem Clin Biochem; 1984 Jan; 22(1):15-9. PubMed ID: 6421989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carbohydrate of the factor VIII/von Willebrand factor in von Willebrand's disease.
    Zimmerman TS; Voss R; Edgington TS
    J Clin Invest; 1979 Nov; 64(5):1298-302. PubMed ID: 315413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factor VIII/von Willebrand factor.
    Zimmerman TS; Ruggeri ZM; Fulcher CA
    Prog Hematol; 1983; 13():279-309. PubMed ID: 6422506
    [No Abstract]   [Full Text] [Related]  

  • 37. [The determination and clinical significance of blood platelet aggregation function and factor VIII in patients with chronic liver disease].
    Xu JY; Xu PY
    Zhonghua Nei Ke Za Zhi; 1986 May; 25(5):282-6, 318. PubMed ID: 3017645
    [No Abstract]   [Full Text] [Related]  

  • 38. Electroblotting of factor VIII/von Willebrand factor multimers after electrophoresis in SDS-agarose gel, discontinuous buffer system.
    Batlle J; López Fernández MF; López Berges C; López Borrasca A
    Br J Haematol; 1983 Sep; 55(1):195-6. PubMed ID: 6411111
    [No Abstract]   [Full Text] [Related]  

  • 39. Von Willebrand activity of low molecular weight human Factor VIII increases by binding to gold granules.
    Furlan M; Perret BA; Beck EA
    Thromb Haemost; 1981 Jun; 45(3):242-6. PubMed ID: 6792738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The nature of the interaction between ristocetin-Willebrand factor VIII coagulant activity molecule.
    Brockway WJ; Fass DN
    J Lab Clin Med; 1977 Jun; 89(6):1295-1305. PubMed ID: 16975
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.